MeiraGTx Holdings (MGTX) Gross Profit (2024 - 2025)
MeiraGTx Holdings (MGTX) reported Gross Profit of $74.9 million for Q4 2025, up 681.39% on a YoY basis from $9.6 million in Q4 2024, and up 77104.12% quarter-over-quarter from $97000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Gross Profit (2024 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Gross Profit for 2 years, with the latest figure at $74.9 million in Q4 2025.
- For the quarter ending Q4 2025, Gross Profit rose 681.39% year-over-year to $74.9 million; the trailing twelve-month figure through Dec 2025 stood at $85.6 million (changed N/A YoY), and the FY2025 full-year result was $76.5 million, up 706.79% from the prior year.
- Gross Profit for Q4 2025 stood at $74.9 million, up from $97000.0 in the prior quarter.
- The five-year high for Gross Profit was $74.9 million in Q4 2025, with the low at -$1.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.89 Mn |
| Dec 31, 2025 | 74.89 Mn |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Sep 30, 2024 | -1.08 Mn |
| Sep 30, 2024 | -1.08 Mn |